Summary
The Court held that the insolvency framework did not permit a successful resolution applicant to withdraw or modify a creditors-approved plan after submission to the adjudicating authority. Its binding force came from the Code, and contractual remedies could not create an exit route. Ebix’s application was not barred by res judicata, but its appeal failed on the merits; Seroco’s appeal also failed. On the joint request in Kundan Care’s case, the Court granted limited, one-time Article 142 relief for consideration of a revised plan, with the original plan prevailing if no revision was agreed.
Issues
- Whether a successful resolution applicant could withdraw or modify a creditors-approved plan pending adjudicating-authority approval.
- Whether contractual principles, plan conditions or residuary jurisdiction supplied such a right.
- Whether Ebix’s third withdrawal application was barred by res judicata and whether the resolution professional breached disclosure duties.
- What relief was appropriate in the three individual appeals.
Provisions considered
- Sections 30 and 31, Insolvency and Bankruptcy Code, 2016A creditors-approved plan submitted for approval binds the applicant and creditors under the statutory framework; Section 31 extends its binding effect to all stakeholders and does not reserve an applicant’s unilateral exit. (¶¶ 101, 112, 125, 139, 150, 153, 157, 204)
- Section 60(5)(c), Insolvency and Bankruptcy Code, 2016Residuary jurisdiction cannot create a withdrawal or renegotiation remedy inconsistent with the Code’s prescribed process. (¶¶ 98, 158, 159, 160, 202)
- Sections 12 and 12A, Insolvency and Bankruptcy Code, 2016The time-bound framework and regulated withdrawal of admitted insolvency applications do not confer a corresponding exit route upon a successful resolution applicant. (¶¶ 126, 127, 138, 145, 147, 202)
- Section 11, including Explanation V, Code of Civil Procedure, 1908The earlier summary and technical dismissals did not adjudicate Ebix’s independent withdrawal prayer on its merits; the third application was not barred. (¶¶ 163, 164, 167, 171, 172, 174)
- Section 29, Insolvency and Bankruptcy Code, 2016The professional must gather accurate information and identify its limitations. On the evidence, Ebix did not establish breach of the duty to provide relevant information. (¶¶ 186, 189, 190, 191)
- Section 32A, Insolvency and Bankruptcy Code, 2016The Court relied on the statutory protection concerning pre-insolvency offences upon qualifying change of management following plan approval when rejecting Ebix’s investigation-based objection. (¶ 181)
- Article 142, Constitution of IndiaOn the parties’ joint request in Kundan Care’s case, limited one-time relief allowed consideration of a revised plan subject to stated safeguards. (¶¶ 195, 196, 197, 204, 206)
Held
- A resolution plan is a product of the Code’s mechanisms, rather than a traditional or statutory contract governed by ordinary contractual remedies. Contractual interpretation may help resolve ambiguity, but frustration, force majeure, damages or similar remedies cannot be imported without a statutory basis to distort the insolvency framework. (¶¶ 112, 114, 116, 118, 125)
- The Code and regulations did not provide an exit or renegotiation mechanism for a successful applicant after creditors’ approval and submission of the plan. Courts could not supply that omission, compel an unwilling creditors’ committee to renegotiate, or use residuary jurisdiction to create a further unregulated bargaining stage. (¶¶ 145, 146, 147, 148, 157, 158, 159, 160, 202, 203, 204)
- Approval under Section 31 makes the plan binding on all stakeholders; it does not leave its binding effect between the applicant and creditors indeterminate beforehand. Open-ended withdrawal conditions undermine viability and implementation. Form H cannot authorize conditions contrary to the governing statute. (¶¶ 150, 152, 153, 154)
- Ebix’s independent withdrawal request had not been consciously decided on its merits in the first application, and the second was dismissed on a technical ground with liberty to refile. The third application was therefore not barred by res judicata, reversing the Appellate Tribunal on that issue alone. (¶¶ 167, 171, 172, 174)
- Ebix’s six-month validity provision concerned the period of negotiation and creditors’ acceptance, rather than imposing a deadline on the adjudicating authority. The surrounding irrevocability provisions and Ebix’s continued pursuit of the plan defeated its asserted contractual entitlement to withdraw. Its due-diligence obligations and statutory protection also answered its investigation-based objections. (¶¶ 175, 178, 179, 180, 181, 182, 183)
- The professional must collect information as accurately as possible and clarify incompleteness. Ebix received the information needed to formulate its plan, was aware of the later tribunal proceedings, and failed to show that the professional knew of the investigations before regulatory disclosure. No breach of the disclosure duty was established. (¶¶ 186, 189, 190, 191)
- For Kundan Care, the parties’ joint request justified one-time Article 142 relief. The creditors’ committee was to decide on the proposed revision. If agreed, the revised plan was to be submitted through the professional within a week thereafter; otherwise the original plan would prevail. The tribunal should decide expeditiously, preferably within two weeks of receiving the application. These directions created no general right to modification or withdrawal. (¶¶ 195, 196, 197, 204)
- Seroco’s proposed reduction in the resolution amount on account of pandemic-related deterioration had no basis in its plan or the Code. Its own plan accepted the binding effect of the creditors’ decision, and contractual frustration could not supply the requested relief. (¶¶ 198, 199, 200)
- The Court urged the tribunals to respect statutory timelines and clear pending plans promptly, recognizing the commercial harm caused by delay. Ebix’s and Seroco’s appeals were dismissed; Kundan Care’s parties were bound by the specific Article 142 directions. (¶¶ 205, 206, 207)
Result
Ebix and Seroco appeals dismissed. Kundan Care matter disposed of through the limited one-time Article 142 directions in paragraph 196.